Denali Therapeutics (DNLI) Prepaid Assets (2017 - 2026)
Denali Therapeutics (DNLI) posted quarterly Prepaid Assets of $35.1 million for Q1 2026, down 42.24% year-over-year from $60.7 million in Q1 2025, and up 6.98% quarter-over-quarter from $32.8 million in Q4 2025.
Denali Therapeutics (DNLI) Prepaid Assets (2017 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has reported Prepaid Assets for 10 consecutive years, with $35.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 42.24% year-over-year to $35.1 million; the TTM figure through Mar 2026 stood at $35.1 million (down 42.24% YoY), while the FY2025 annual figure was $32.8 million, up 2.1% from the prior year.
- Prepaid Assets rose to $35.1 million in Q1 2026 per DNLI's latest filing, from $32.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $60.7 million in Q1 2025 and bottomed at $29.6 million in Q4 2023.
- Historically, Prepaid Assets has averaged $35.9 million across 5 years, with a median of $33.6 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 184.33% — and 2026, when it tumbled 42.24%.
- Denali Therapeutics' Prepaid Assets stood at $36.1 million in 2022, then slipped by 17.94% to $29.6 million in 2023, then advanced by 8.37% to $32.1 million in 2024, then increased by 2.1% to $32.8 million in 2025, then gained by 6.98% to $35.1 million in 2026.
- Business Quant data shows DNLI's Prepaid Assets at $35.1 million in Q1 2026, $32.8 million in Q4 2025, and $34.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.39 Mn |
| Mar 31, 2026 | 35.07 Mn |
| Dec 31, 2025 | 32.78 Mn |
| Sep 30, 2025 | 34.39 Mn |
| Jun 30, 2025 | 35.75 Mn |
| Mar 31, 2025 | 60.71 Mn |
| Dec 31, 2024 | 32.11 Mn |
| Sep 30, 2024 | 32.28 Mn |
| Jun 30, 2024 | 32.34 Mn |
| Mar 31, 2024 | 36.71 Mn |
| Dec 31, 2023 | 29.63 Mn |
| Sep 30, 2023 | 33.63 Mn |
| Jun 30, 2023 | 33.08 Mn |
| Mar 31, 2023 | 36.71 Mn |
| Dec 31, 2022 | 36.10 Mn |
| Sep 30, 2022 | 32.47 Mn |
| Jun 30, 2022 | 45.58 Mn |
| Mar 31, 2022 | 30.91 Mn |
| Dec 31, 2021 | 30.60 Mn |
| Sep 30, 2021 | 15.14 Mn |